Onconetix Inc ONCO 深 滬
交易中 05-18 11:14:38 美东时间
0.3601
-0.014
-3.72%
華盛通- 最 高0.38
- 今 開0.38
- 成交量 24.24万股
- 最 低 0.36
- 昨 收 0.374
- 總市值 412.84万
- 52周最高 36.125
- 市盈率 靜 --
- 換手率 2.11%
- 52周最低 0.36
- 委 比 0.00%
- 總股本 1146.46万
- 歷史最高 1545300.00
- 量 比 1.86
- 振 幅 5.35%
- 歷史最低 0.36
- 每 手 1
- 風險率 9.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year. The company reported $21.457 thousand in sales
05-13 21:48
Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp
Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp Onconetix reported Q1 2026 progress at wholly owned Swiss subsidiary Proteomedix, highlighting two peer-reviewed studies supporting Proclarix use to cut unnecessary prostate biopsies. Proteomedix initiated PRIME, a US m
05-13 21:26
Onconetix Q1 net loss narrows 50.7% to $4.21 million
Onconetix Q1 net loss narrows 50.7% to $4.21 million Onconetix posted net loss of $4.21 million, narrowing from year-earlier net loss applicable to common stockholders of $9.72 million. Revenue fell 78.9% to $21,457, swinging gross profit to gross loss of $1,655. Operating loss narrowed to $10.23 mi
05-13 20:52
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 56.4% to $0.16 du...
04-14 01:05
Onconetix Announces Realbotix Delivers Its First Vinci-Equipped Humanoid Robot To Ericsson
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") is providing the following summary of a press release issued by Realbotix Corp., parent of Realbotix LLC ("Realbotix"), the target of Onconetix's previously
04-09 20:35
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Axe Compute (NASDAQ:AGPU) shares increased by 23.0% to $4.38 during We...
04-02 05:05
Onconetix Appoints David White CEO, Effective March 18, Succeeding Interim CEO Karina Fedasz
Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") today announced the appointment of David White as Chief Executive Officer, effective March 18, 2026, and the appointment of Sammy Dorf as a member of the
03-31 20:31
What's Going On With Onconetix Shares On Friday?
Onconetix (ONCO) shares surge 71% premarket following the Realbotix acquisition update and 1-for-5 reverse split.
03-27 20:15
Market-Moving News for March 27th
U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 revenue guidance that exceeded its earlier outlook AZN: 3% | AstraZeneca shares are trading higher after the
03-27 19:18
